Associate Professor of Neurology
Neurology
Dr. Phioanh Nghiemphu, MD
|
|
Give Review
Dr. Phioanh Nghiemphu works in the field of Neurology. She studied medicine at Albert Einstein College of Medicine of Yeshiva University. Phioanh Nghiemphu is also a published MD. She has 51 publication published. The most recent publication is: Clinical aggressiveness of malignant gliomas is linked to augmented metabolism of amino acids. Phioanh Nghiemphu is registered with Medicare.
Publications
- Clinical aggressiveness of malignant Gliomas is linked to augmented metabolism of amino acids.
- pH-weighted molecular imaging of Gliomas using amine chemical exchange saturation transfer MRI.
- MRI perfusion measurements calculated using advanced deconvolution techniques predict survival in recurrent glioblastoma treated with bevacizumab.
- Relationship Between [(18)F]FDOPA PET Uptake, Apparent Diffusion Coefficient (ADC), and Proliferation Rate in Recurrent Malignant Gliomas.
- Tumor suppressive miR-148a is silenced by CpG island hypermethylation in IDH1 mutant Gliomas.
- Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacy.
- Increased sensitivity to radiochemotherapy in IDH1 mutant glioblastoma as demonstrated by serial quantitative MR volumetry.
- C-terminally truncated form of αB-crystallin is associated with IDH1 R132H mutation in anaplastic Astrocytoma.
- Nonlinear distortion correction of diffusion MR images improves quantitative DTI measurements in glioblastoma.
- Short-interval estimation of proliferation rate using serial diffusion MRI predicts progression-free survival in newly diagnosed glioblastoma treated with radiochemoth...
- Recurrent Glioblastoma Treated with Bevacizumab: Contrast-enhanced T1-weighted Subtraction Maps Improve Tumor Delineation and Aid Prediction of Survival in a Multicent...
- Pretreatment ADC Histogram Analysis Is a Predictive Imaging Biomarker for Bevacizumab Treatment but Not Chemotherapy in Recurrent Glioblastoma.
- Identifying the mesenchymal molecular subtype of glioblastoma using quantitative volumetric analysis of anatomic magnetic resonance images.
- Probabilistic radiographic atlas of glioblastoma phenotypes.
- Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome.
- Quantitative probabilistic functional diffusion mapping in newly diagnosed glioblastoma treated with radiochemotherapy.
- Evaluation of High Ipsilateral Subventricular Zone Radiation Therapy Dose in Glioblastoma: A Pooled Analysis.
- Imaging biomarkers for antiangiogenic therapy in malignant Gliomas.
- Pre- and post-contrast three-dimensional double inversion-recovery MRI in human glioblastoma.
- Persistent Diffusion-Restricted Lesions in Bevacizumab-Treated Malignant Gliomas Are Associated with Improved Survival Compared with Matched Controls.
- Bevacizumab as first-line therapy for glioblastoma.
- Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-cen...
- Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin.
- MRI in patients with high-grade Gliomas treated with bevacizumab and chemotherapy.
- Phase II pilot study of bevacizumab in combination with temozolomide and regional radiation therapy for up-front treatment of patients with newly diagnosed glioblastom...
- Safety of anticoagulation use and bevacizumab in patients with glioma.
- The L84F polymorphic variant of human O6-methylguanine-DNA methyltransferase alters stability in U87MG glioma cells but not temozolomide sensitivity.
- A phase I trial of tipifarnib with radiation therapy, with and without temozolomide, for patients with newly diagnosed glioblastoma.
- PTEN dosage is essential for neurofibroma development and malignant transformation.
- Relationship between gene expression and enhancement in glioblastoma multiforme: exploratory DNA microarray analysis.
- Time course of imaging changes of GBM during extended bevacizumab treatment.
- Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma.
- Relationship between survival and edema in malignant Gliomas: role of vascular endothelial growth factor and neuronal pentraxin 2.
- Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain.
- Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis.
- Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment.
- Bevacizumab and chemotherapy for recurrent glioblastoma: a single-institution experience.
- Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy.
- Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent Gliomas.
- Safety and efficacy of erlotinib in first-relapse glioblastoma: a phase II open-label study.
- Apparent diffusion coefficient histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma.
- Functional diffusion maps (fDMs) evaluated before and after radiochemotherapy predict progression-free and overall survival in newly diagnosed glioblastoma.
- Anatomic localization of O6-methylguanine DNA methyltransferase (MGMT) promoter methylated and unmethylated tumors: A radiographic study in 358 de novo human glioblast...
- Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumab.
- Quantification of edema reduction using differential quantitative T2 (DQT2) relaxometry mapping in recurrent glioblastoma treated with bevacizumab.
- Nonlinear registration of diffusion-weighted images improves clinical sensitivity of functional diffusion maps in recurrent glioblastoma treated with bevacizumab.
- High Order Diffusion Tensor Imaging in Human Glioblastoma.
- Cell invasion, motility, and proliferation level estimate (CIMPLE) maps derived from serial diffusion MR images in recurrent glioblastoma treated with bevacizumab.
- Quantitative volumetric analysis of conventional MRI response in recurrent glioblastoma treated with bevacizumab.
- Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme.
Schools
Albert Einstein College of Medicine of Yeshiva University
Beth Israel Med Center
Procedures Preformed
- EEG (Electroencephalogram)
Conditions Treated
- Alzheimer's Disease
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Convulsions
- Dementia
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Education
-
UCLA Medical Center -
Stanford University -
Mount Sinai Beth Israel -
Albert Einstein College of Medicine of Yeshiva University
Hospital
-
Ronald Reagan UCLA Medical Center
Drug Facts
| NPI NUMBER | 1871519017 | |
| NPPES Provider LastName | NGHIEMPHU | |
| NPPES Provider FirstName | PHIOANH | |
| NPPES Provider ZIPCode | 900950001 | |
| NPPES Provider State | CA | |
| Specialty Description | Neurology | |
| Total Claim Count | 239.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1871519017 |
| Last Name Of The Provider | NGHIEMPHU |
| First Name Of The Provider | PHIOANH |
| View All |
Similar Doctors
|
|
Dr. Shaun A. Hussain, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tamika M. Burrus, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julienne R. Jacobson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rhonda R. Voskuhl, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Gregory P. Lekovic, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William K. Engel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel H. Geschwind, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Daniel P. Holschneider, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Hui Gong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert H. Baloh, MD
This Doctor is OpenDoctor Recommended.
|